Newsletter
#1 – Measuring your arterial age to prevent heart diseases – Ted Baldwin – Imageens

Impulse – Meeting Healthcare Pioneers

#1 – Measuring your arterial age to prevent heart diseases – Ted Baldwin – Imageens

Cardiovascular diseases represent the leading cause of deaths worldwide. Despite the permanent progress in the treatment of such conditions, targeted prevention approaches remain a key solution to address this issue.…
February 2, 2022

#1 – Measuring your arterial age to prevent heart diseases – Ted Baldwin – Imageens

Cardiovascular diseases represent the leading cause of deaths worldwide. Despite the permanent progress in the treatment of such conditions, targeted prevention approaches remain a key solution to address this issue.

This is the challenge that Imageens, a Paris-based startup led by Ted Baldwin, is tackling through the application of artificial intelligence to medical imaging, with the aim to quantify your arterial age. This specific biomarker unvails unique opportunities to anticipate heart conditions for people at moderate risk, with the promise to inform better clinical care decisions.

We exchanged with Ted on the burden that cardiovascular diseases represent on a global level, the power of AI applied to medical imaging to discover early indicators of these pathologies, and how these insights can drive better personalized prevention programs to stay away from them.

Timeline:

01:50 – 05:18: origins of Imageens
06:23 – 08:16: unmet need that Imageens is addressing
08:53 – 12:56: existing cardiac risk scores and the arterial age concept
13:10 – 15:36: technical approach to quantify the arterial age using MRI and AI
15:41 – 20:10: relationship between biological and arterial ages
20:32 – 22:56: MESA trial led by Johns Hopkins University and its link to the discovery of cardiac risk scores
23:26 – 30:09: Imageens softwares Artfun+ and LABEL, their functioning and role in predictive imaging biomarkers discovery
30:21 – 31:05: moving beyond MRI to other imaging modalities
31:35 – 33:21: target patient population and access to Imageens technology
33:43 – 36:09: acceptance by physicians and the medical community
36:48 – 37:30: patient journey description
38:00 – 40:24: moving towards predictive analysis of the optimal cardiac prevention program

What we also talked with Ted about:

If you want to know more about Imageens, we invite you to consult their website: https://www.imageens.com/

You can contact Ted through LinkedIn or by email: [email protected]

If you want to give me feedback on the episode, ask questions or suggest potential guests, feel free to do so through LinkedIn or by email: [email protected]

You may also like

Top Health Podcasts. Delivered to Your Inbox and Eardrums.

Join Our Newsletter

Proudly supported by:

cover
What Will Variant Sigma Look Like? with Michael T. Osterholm, Ph.D., Regents Professor, Division of Environmental Health Science; Director, Center for Infectious Disease Research and Policy (CIDRAP) University of Minnesota